GLP-1 medications may be appropriate for: Individuals who are overweight or obese Patients with Type 2 diabetes Those with weight-related health conditions Patients who have not had success with diet and exercise alone These medications must be prescribed and monitored by a qualified provider
These findings highlight the importance of optimizing escalation protocols in future studies
Sign up to all DiabetesontheNet journals By clicking Subscribe, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters
Food Research International , 152, 110891
Step 4: monitor and adjust Track three things after each injection: site used, any reactions or discomfort (rated 1-10), and nausea level over the next 24 hours
it is a precise, evidence-based strategy for engaging one of the bodys most powerful and wide-ranging signaling systems